219 related articles for article (PubMed ID: 28962616)
1. Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.
Siriwardhana C; Fang R; Salanti A; Leke RGF; Bobbili N; Taylor DW; Chen JJ
Malar J; 2017 Sep; 16(1):391. PubMed ID: 28962616
[TBL] [Abstract][Full Text] [Related]
2. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon.
Lloyd YM; Fang R; Bobbili N; Vanda K; Ngati E; Sanchez-Quintero MJ; Salanti A; Chen JJ; Leke RGF; Taylor DW
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986889
[No Abstract] [Full Text] [Related]
3. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
[TBL] [Abstract][Full Text] [Related]
4. The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.
Vanda K; Bobbili N; Matsunaga M; Chen JJ; Salanti A; Leke RFG; Taylor DW
Front Immunol; 2021; 12():610108. PubMed ID: 33717094
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.
Babakhanyan A; Fang R; Wey A; Salanti A; Sama G; Efundem C; Leke RJ; Chen JJ; Leke RG; Taylor DW
Malar J; 2015 Dec; 14():480. PubMed ID: 26626275
[TBL] [Abstract][Full Text] [Related]
6. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
[TBL] [Abstract][Full Text] [Related]
7. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
[TBL] [Abstract][Full Text] [Related]
8. High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.
Tutterrow YL; Salanti A; Avril M; Smith JD; Pagano IS; Ako S; Fogako J; Leke RG; Taylor DW
PLoS One; 2012; 7(6):e40049. PubMed ID: 22761948
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to full-length and the DBL5 domain of VAR2CSA in pregnant women after long-term implementation of intermittent preventive treatment in Etoudi, Cameroon.
Djontu JC; Lloyd YM; Megnekou R; Seumko'o RMN; Salanti A; Taylor DW; Leke RGF
PLoS One; 2020; 15(8):e0237671. PubMed ID: 32797068
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to the full-length VAR2CSA and its DBL domains in Cameroonian children and teenagers.
Fodjo BA; Atemnkeng N; Esemu L; Yuosembom EK; Quakyi IA; Tchinda VH; Smith J; Salanti A; Bigoga J; Taylor DW; Leke RG; Babakhanyan A
Malar J; 2016 Nov; 15(1):532. PubMed ID: 27814765
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria.
Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A
Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682
[TBL] [Abstract][Full Text] [Related]
12. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
[TBL] [Abstract][Full Text] [Related]
13. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
[TBL] [Abstract][Full Text] [Related]
14. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
[TBL] [Abstract][Full Text] [Related]
15. High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women.
McLean ARD; Opi DH; Stanisic DI; Cutts JC; Feng G; Ura A; Mueller I; Rogerson SJ; Beeson JG; Fowkes FJI
Front Immunol; 2021; 12():644563. PubMed ID: 34220804
[TBL] [Abstract][Full Text] [Related]
16. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
17. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
[TBL] [Abstract][Full Text] [Related]
18. VAR2CSA-Mediated Host Defense Evasion of
Tomlinson A; Semblat JP; Gamain B; Chêne A
Front Immunol; 2020; 11():624126. PubMed ID: 33633743
[TBL] [Abstract][Full Text] [Related]
19. Functional Antibodies against Placental Malaria Parasites Are Variant Dependent and Differ by Geographic Region.
Doritchamou J; Teo A; Morrison R; Arora G; Kwan J; Manzella-Lapeira J; Medina-Maldonado S; Langhorne J; Hviid L; Narum DL; Dicko A; Fried M; Duffy PE
Infect Immun; 2019 Jul; 87(7):. PubMed ID: 30988054
[TBL] [Abstract][Full Text] [Related]
20. Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2.
Taylor DW; Bobbili N; Khadka VS; Quakyi IA; Leke RG
Malar J; 2017 Feb; 16(1):58. PubMed ID: 28148260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
